|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
07.05.26 - 17:54
|
Zoetis Inc. Q1 Sales Increase (AFX)
|
|
|
WASHINGTON (dpa-AFX) - Zoetis Inc. (ZTS) revealed a profit for first quarter of $601 millionThe company's bottom line came in at $601 million, or $1.42 per share. This compares with $602 million, ......
|
|
|
|
|
|
|
|
|
|
|
07.05.26 - 13:03
|
Zoetis Announces First Quarter 2026 Results (Business Wire)
|
|
|
Revenue of $2.3 Billion, Growing 3%, and Net Income of $601 Million, or $1.42 per Diluted Share, Flat and Increasing 6%, Respectively, on a Reported Basis
Adjusted Net Income of $646 Million, or Adjusted Diluted EPS of $1.53
Flat Organic Operational Growth in Revenue and 1% Organic Operational Growth in Adjusted Net Income
Revises Full Year 2026 Revenue Guidance to $9.680 - $9.960 Billion with Organic Operational Revenue Growth of 2% to 5%
Revises Full Year 2026 Guidance for Organic Operational Growth in Adjusted Net Income to 2% to 6%
Revises Guidance for Diluted EPS on an Adjusted Basis to $6.85 to $7.00
PARSIPPANY, N.J.--(BUSINESS WIRE)--$ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS), the world's leading animal health company, today reported its financial results for the first quarter of 2026.
The company reported revenue of $2.3 billion for the first quarter of 2026, an increase of 3% compared with the first quarter of 2025 and flat on an organic operational1 basis. Net income for the first quarter of 20...
|
|
|
|
|
|
|
30.04.26 - 23:06
|
Techcyte Announces $15 Million Capital Raise Led by Van Tuyl Companies to Support Growth and Path to Profitability (Business Wire)
|
|
|
OREM, Utah--(BUSINESS WIRE)--#AIinHealthcare--Techcyte, a leading provider of AI-powered digital diagnostics for anatomic and clinical pathology, today announced the completion of a $15 million capital raise led by Van Tuyl Companies, with participation from existing investors Zoetis Inc. (“Zoetis”) and Mayo Clinic.
This funding reinforces Techcyte's ability to execute on its strategic priorities and supports its path to profitability. Techcyte's veterinary business is currently profitable, and the company expects its environmental and human segments to reach profitability by next year. This progress comes as diagnostic laboratories worldwide face increasing pressure to deliver accurate results while managing constrained resources, rising test volumes, and ongoing workforce shortages.
At the same time, digital pathology is emerging as a viable path to improved operational efficiency while expanding access to diagnostic expertise through remote workflows. Techcyte's Fusion platform is designed to su...
|
|
|
|
|
|
|
16.04.26 - 23:45
|
XETR: DIVIDEND/INTEREST INFORMATION - 20.04.2026 - US98978V1035 (XETRA)
|
|
|
Das Instrument ZOE US98978V1035 ZOETIS INC. CL.A DL -,01 EQUITY wird cum Dividende/Zinsen gehandelt am 17.04.2026 und ex Dividende/Zinsen am 20.04.2026
The instrument ZOE US98978V1035 ZOETIS INC. CL.A DL -,01 EQUITY has its pre-dividend/interest day on 17.04.2026 and its ex-dividend/interest day on 20.04.2026...
|
|
|
|
|
15.04.26 - 14:00
|
Here Are Wednesday′s Top Wall Street Analyst Research Calls: Align Technology, American Tower, Autodesk, Autoliv, Chime Financial, Cloudflare, SolarEdge Technologies, Zoetis, and More (24/7 Wall St.)
|
|
|
Pre-Market Stock Futures: The futures are trading flat after a stellar day across Wall Street, with all major indices finishing deep in positive territory. Traders cited an improving outlook for the Iran War, better-than-expected inflation data, and a counterintuitive impulse, perhaps due to sentiment indicators being so low. The tech-heavy Nasdaq got another big day ... Here Are Wednesday's Top Wall Street Analyst Research Calls: Align Technology, American Tower, Autodesk, Autoliv, Chime Financial, Cloudflare, SolarEdge Technologies, Zoetis, and More...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
